Related references
Note: Only part of the references are listed.Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin
Jiro Watari et al.
GUT AND LIVER (2020)
Statins Were Associated with a Reduced Gastric Cancer Risk in Patients with Eradicated Helicobacter Pylori Infection: A Territory-Wide Propensity Score Matched Study
Ka Shing Cheung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Statins and metachronous recurrence after endoscopic resection of early gastric cancer: a nationwide Korean cohort study
Hyunsoo Chung et al.
GASTRIC CANCER (2020)
Mucosal microbiome dysbiosis in gastric carcinogenesis
Olabisi Oluwabukola Coker et al.
GUT (2018)
Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
Rui M. Ferreira et al.
GUT (2018)
MICROBIAL COMPOSITION IS EFFECTIVELY IMPROVED BY COMBINATION THERAPY WITH FECAL MICROBIAL TRANSPLANTATION AND MULTIPLE ANTIBIOTICS FOR ULCERATIVE COLITIS
Dai Ishikawa et al.
INFLAMMATORY BOWEL DISEASES (2018)
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
Il Ju Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Fusobacterium nucleatum in gastroenterological cancer: Evaluation of measurement methods using quantitative polymerase chain reaction and a literature review
Kensuke Yamamura et al.
ONCOLOGY LETTERS (2017)
Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan
Genki Mori et al.
GASTRIC CANCER (2016)
Other Helicobacters and gastric microbiota
Chloe De Witte et al.
HELICOBACTER (2016)
Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection
Seiichiro Abe et al.
ENDOSCOPY (2015)
Long-Term Alteration of Intestinal Microbiota in Patients with Ulcerative Colitis by Antibiotic Combination Therapy
Shigeo Koido et al.
PLOS ONE (2014)
Probiotics in the gastrointestinal diseases of the elderly
G. Malaguarnera et al.
JOURNAL OF NUTRITION HEALTH & AGING (2012)
Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion
Kimihiko Yanaoka et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Effective Reduction of Gastric Cancer Risk With Regular Use of Nonsteroidal Anti-Inflammatory Drugs in Helicobacter Pylori-Infected Patients
Chun-Ying Wu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer:: an open-label, randomised controlled trial
Kazutoshi Fukase et al.
LANCET (2008)
Lemierre syndrome
MD Nadkarni et al.
JOURNAL OF EMERGENCY MEDICINE (2005)
The role of probiotic bacteria in cancer prevention
K Hirayama et al.
MICROBES AND INFECTION (2000)
Share Paper
